CoChat

Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?

Open access
Hollestelle, Antoinette, Schutte, Mieke · 2009 · Cancer Research

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

To the Editor: In support of the recent article by Chambers (1), we wish to share our data on the origin of the MDA-MB-435 and M14 cell lines. Chambers claims that it is most plausible that both cell lines represent MDA-MB-435 based on two X chromosomes in the MDA-MB-435 karyotype, whereas M14 had been derived from a man (1). However, karyotyping does not discriminate between paternal and maternal alleles and thus does not exclude loss of the Y chromosome combined with reduplication of the X chromosome. We previously reported an allelotype on human breast cancer cell lines, including MDA-MB-435 (2). Our analyses did not detect Y chromosome sequences and revealed heterozygosity of polymorphic microsatellite markers at Xp, implying that MDA-MB-435 had indeed been derived from a woman. Our MDA-MB-435 cell line was obtained directly from American Type Culture Collection at passage 239 and M14 from its originator at passage 10 (3). We confirmed that the cell lines were identical by microsatellite analysis, in concordance with Rae and colleagues (4), and we also identified unique mutations in the p53 and p16 genes in both cell lines (3). Altogether, it can be concluded conclusively that MDA-MB-435 and M14 are breast cancer cell lines.The melanocytic phenotype of MDA-MB-435 may be explained by our recent molecular characterization of MDA-MB-435 and 40 other human breast cancer cell lines (3). Microarray gene expression profiling had revealed two major subgroups among thebreast cancer cell lines: luminal type and basal type. As anticipated, MDA-MB-435 was basal type, along with 14 other cell lines, and unsupervised hierarchical clustering showed strong similarity among the basal-type cell lines. It is unlikely that the 15 basal-type cell lines all are of melanocytic origin because 4 of them carry a BRCA1 mutation and 1 has the CHEK2 1100delC mutation. Also, 10 of the basal-type cell lines, including MDA-MB-435, are of the normal-like intrinsic subtype; a molecular subtype that had been defined on (uncultured) clinical breast tumors. Most interestingly, analysis of the genetic status of 27 well-known cancer genes in our collection of breast cancer cell lines identified two subtype-specific gene mutation profiles (3). The basal mutation profile involved mutations in the BRCA1, RB1, RAS, and BRAF genes and deletions of p16 and p14ARF. Particularly, the combination of mutations in p16, RB1, and RAS pathway genes is characteristic for melanoma. These results thus suggest that basal-type breast cancers may have a genetic basis similar to melanomas, explaining their melanocytic phenotype and perhaps also their rather aggressive clinical course.No potential conflicts of interest were disclosed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-09-2396

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 38

Metadata

Authors
Hollestelle, A., & Schutte, M.
Affiliations
Erasmus MC (NL)
Venue
Cancer Research
Published
2009-10-01
Volume
69
Issue
19
Pages
7893-7893
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2109957503
Cited by
38
References
4
Citations by year
2020: 1 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 4 · 2013: 3 · 2012: 4
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
MDA-MB-435, breast cancer cell lines, cell line origin, X chromosome loss, Y chromosome loss, microsatellite markers, basal-like breast cancer, luminal breast cancer, molecular subtypes, TP53 mutation, p16 mutation, gene expression profiling, allelotype
MeSH terms
Breast Neoplasms, Female, Humans, Melanoma, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma? https://app.cochat.ai/papers/10.1158/0008-5472.can-09-2396
The paper
Hollestelle, A., & Schutte, M. (2009). Comment Re: MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma? Cancer Research. https://doi.org/10.1158/0008-5472.can-09-2396

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.